What do I need to know about the Delta variant?
What is the Delta variant?
The Delta variant, also known as B.1.617.2, was first identified in India last fall. Since then, the variant has been reported in many countries and in all 50 states in the U.S.
Should we be concerned?
Yes, the Centers for Disease Control and Prevention (CDC) has classified the Delta variant as a “variant of concern.” This means that it has been shown that this variant:
spreads more easily than other strains of COVID-19.
causes increased hospitalizations and deaths.
What can I do to prevent getting the Delta variant?
The number one thing you can do to prevent getting severe illness from the Delta variant is to get vaccinated!
- Vaccine clinics
- Although the vaccine will not protect you 100% from getting the virus, it will likely prevent you from having severe illness, being hospitalized and death.
- Getting vaccinated helps protect those who are not eligible to be vaccinated (under 12 years of age) from contracting the virus.
- Individuals who are not fully vaccinated should:
- Get vaccinated as soon as possible and continue masking until they are fully vaccinated. With the Delta variant, this is more urgent than ever.
- Wear a mask that covers your nose and mouth.
- Maintain six feet social distance.
- Avoid crowds and poorly ventilated areas.
- Wash your hands often with soap and water or use hand sanitizer if soap and water are not available.
- Cover coughs and sneezes.
- Clean and disinfect high touch surfaces daily.
- Monitor their health daily for COVID-19 symptoms.
For more information about COVID-19, call our Office: 540-217-0911
2 CDC has updated its recommendations for COVID-19 vaccines with a preference for mRNA (Pfizer-BioNTech or Moderna) vaccines. Learn more about the updated guidance on the use of Janssen (Johnson & Johnson) COVID-19 vaccine.
3 The primary series of these vaccinations includes a third dose for people ages 18 years and older with moderate to severe immunocompromise. This third dose occurs 28 days after the second dose in the primary series.
4 The primary series of this vaccination includes a third dose for people ages 5–17 years with moderate to severe immunocompromise. The third dose occurs 28 days after the second dose in the primary series.
5 You should get your second shot as close to the recommended 3-week or 4-week interval as possible. You should not get the second dose early.